Europe/India/Near East USA Asia
Bachem AG Bachem Americas, Inc. Bachem Japan K.K.
Hauptstrasse 144 3132 Kashiwa Street Ueno Bldg, 8F
4416 Bubendorf - Switzerland Torrance, CA 90505 - USA 1-9-10 Nihonbashi-Horidome cho, Chuo-ku
Tel +41 58 595 2021 Tel +1 888 422 2436 Tokyo 103-0012 - Japan
Fax +41 58 595 2040 Tel +1 888 4BACHEM Tel +81 3 6661 0774
Email sales.ch@bachem.com Fax +1 310 539 9428 Email sales.jp@bachem.com
  E-mail sales.us@bachem.com  

CORPORATE GOVERNANCE

Honorary Chairman

Peter Grogg (1942), Dr. h.c., Honorary Chairman, Swiss

since 2012

Peter Grogg founded Bachem AG in 1971 and was the CEO until 2002 and Chairman of the Board of Bachem Holding AG until 2012. He is Chairman of the Board of Ingro Finanz AG.

 

Board of Directors

Kuno Sommer (1956), Ph.D. in Business Administration, Chairman*, Swiss

since 2012, elected until 2021

Dr. Kuno Sommer, Ph.D. University of Basel, worked for Roche from 1986 to 1999 in various functions, including four years  in the USA. Kuno Sommer was ultimately a member of the Executive Committee of Roche, responsible for the Flavours and Fragrances division, today Givaudan. From 2000 to 2006 he was CEO of Berna Biotech. Kuno Sommer is Vice Chairman of the Board of Polyphor AG, Chairman of the Board of Sunstar Holding AG, of PDS Pathology Data Systems AG, of Kenta Biotech AG and of Targimmune Therapeutics AG.

 

Nicole Grogg Hötzer (1973), Graduate Biologist, Vice Chairwoman, Swiss

since 2011, elected until 2021

Nicole Grogg Hötzer graduated in Biology at Basel University in 1999. Afterwards, she worked in various positions in the field of regulatory affairs. In 2002 Nicole Grogg Hötzer began her postgraduate studies in Business Administration at the University of Applied Sciences Basel which she completed successfully in 2004. Nicole Grogg Hötzer is Vice Chairwoman of the Board of Directors of Ingro Finanz AG, of Hotel Bad Schauenburg AG and of Sunstar Holding AG as well as member of the Board of Directors of MFC Beteiligungs AG and of Breiten Immobilien AG.

 

Jürgen Brokatzky-Geiger (1952), Dr. rer.nat., Member*, German

since 2009, elected until 2021

Dr. Jürgen Brokatzky-Geiger graduated with a Ph.D. in chemistry from the University of Freiburg, Germany, in 1982. He joined Ciba-Geigy Ltd. in 1983 as a Laboratory Head in the Pharmaceuticals Division. After a job rotation in the United States, he held positions of increasing responsibility in Research and Development (R&D) including Group Leader of Process R&D, Head of Process R&D, and Head of Process Development and Pilot Plant Operations. During the merger of Ciba-Geigy and Sandoz in 1996, Dr. Jürgen Brokatzky-Geiger was appointed Integration Officer of Technical Operations. He later became the Head of Chemical and Analytical Development and served as the Global Head of Technical R&D from 1999 to August 2003. From September 2003 to February 2014, he was appointed as Global Head of Human Resources and member of the Executive Committee of Novartis. Until his retirement at the end of October 2017, Dr. Jürgen Brokatzky-Geiger was Global Head of Corporate Responsibility of Novartis.

 

Helma Wennemers (1969), Prof. Dr., Member, German

since 2014, elected until 2021

Helma Wennemers graduated with a diploma degree in chemistry from Johann-Wolfgang-Goethe University in Frankfurt in 1993. Three years later she earned a doctorate degree from Columbia University, New York. She then pursued post-doctoral studies at Nagoya University before accepting the "Bachem-Stiftungs-Assistenzprofessur" at the University of Basel in 1999, where she became Associate Professor in 2003. Since 2011, she is Professor at the Laboratory of Organic Chemistry at ETH Zürich. Helma Wennemers research has been recognized by several awards including the "Inhoffen Medal" (2017), the "Pedler Award" (2016) and the "Leonidas Zervas Award" (2010). She has also been awarded with numerous honorary lectureships such as the "Calvin Lecture" of UC Berkeley (2017), "The Chemical Record Lectureship" (2017), the "David Ginsburg Lectureship" at the Technion in Haifa (2010) and was named a "Fellow of the Royal Society of Chemistry" (2013).

 

Thomas Früh (1957), Dr. chem. ETH, Member*, Swiss

since 2020, elected until 2021

Dr. Thomas Früh has occupied a number of different positions in the company since 1997; from April 2012 to the end of 2019, he was Chief Executive Officer and Chairman of Bachem's Corporate Executive Committee. He completed his education as a chemist at the Swiss Federal Institute of Technology in Zurich (ETHZ) and then was a research fellow at Harvard University in Cambridge. Before he joined Bachem, he held various research and development positions at Ciba-Geigy and Novartis. Thomas Früh is Vice President of the business association scienceindustries, Board member of the Chamber of Commerce of both Basel and President of the Board of the foundation SimplyScience.

 

Steffen Lang (1967), Ph.D., Member, German/Swiss

since 2020, elected until 2021

Dr. Steffen Lang has been Global Head of Novartis Technical Operations (NTO) since 2017. He is a member of the Executive Committee of Novartis. Prior to his current appointment, Steffen Lang served as Global Head of Biologics Technical Development and Manufacturing within NTO from 2015 to 2017. He joined Novartis in 1994 as Head of Laboratory in Research, and over the years has held various positions within Pharmaceuticals Development, including Global Head of Technical Research and Development from 2009 to 2015. Steffen Lang holds a doctorate in pharmaceutical technology from the Swiss Federal Institute of Technology (ETHZ), and a master's degree in pharmaceutical sciences from the University of Heidelberg in Germany.

 

 

 

*Member of the Compensation Committee

 

Corporate Executive Committee

Thomas Meier (1968), Degree in Chemistry and as Industrial Engineer, CEO, Swiss

since 2020

Thomas Meier joined Bachem AG in 1993 as Team Head, Active Pharmaceutical Ingredients. From 2001 to 2004, he headed up peptide manufacturing at Peninsula Laboratories, Inc. in San Carlos, California. Upon his return to Switzerland, he was in charge of solid-phase peptide manufacturing for Bachem AG in Bubendorf. He assumed overall responsibility for production at the Bubendorf site in 2013, and was appointed COO Europe in August 2017, with responsibility for all production sites in Switzerland, Germany, and the UK. He was appointed COO of the Bachem Group and member of the Corporate Executive Committee in 2019. Since January 1, 2020 Thomas Meier is CEO of the Bachem Group and Chairman of the Corporate Executive Committee.

After an apprenticeship as chemical laboratory technician at the ETH in Zurich, Thomas Meier obtained a degree in chemistry from the ZHAW School of Engineering. He obtained in parallel a degree as Industrial Engineer STA (Swiss Technical Association) and completed the Advanced Management Programme at INSEAD Business School, Fontainebleau/Paris.

 

Stephan Schindler (1964), business economist HWV, EMBA, CFO, Swiss

since 2009

Stephan Schindler joined Bachem Holding AG as Chief Financial Officer (CFO) and member of the Corporate Executive Committee in 2009. In 1991, he assumed a first management position in informatics as Head of Information Center at Patria Insurances in Basel. In parallel, he persistently pursued his extra occupational studies in business economics, finance and control. After his graduation, he joined F. Hoffmann- La Roche Ltd in Basel where he assumed various positions in Corporate Finance. With the unbundling of the division in 2001, he took over the accounting & reporting department at Roche Vitamins Ltd. Until 2009, he was Head Finance & Control Switzerland at DSM Nutritional Products Ltd, Kaiseraugst. Stephan Schindler holds a degree of International Executive MBA Zurich/Boston. Furthermore, he is a member of the Board of Directors of Arcondis (Holding) AG and a Board member of Columna Collective Foundation - Client Invest, Winterthur.

 

Günther Loidl (1970), Dr. rer. nat., CTO, German

since 2015

Guenther Loidl joined Bachem in 2000. He held several functions in Research and Development (R&D) and Active Pharmaceutical Ingredient Manufacturing and became Vice President R&D in 2012. Since 2015, he is CTO of the Bachem Group and a member of the Corporate Executive Committee. He studied chemistry in Regensburg (Germany) and Leeds (UK) and obtained his doctorate under the supervision of Prof. Dr. Luis Moroder at the Max Planck Institute of Biochemistry in Martinsried (Germany).

 

Anne-Katrhin Stoller (1974), Dr. phil. nat., CMO, German

since 2018

Anne-Kathrin Stoller joined Bachem AG in Bubendorf in 2006 and headed the Business Development Unit from 2008 to 2010. Subsequently, she was responsible for the Business Development & Sales Department, first locally and finally for the entire region Europe. Serving as Vice President and Department Head she was also a member of the local management team in Bubendorf. Since January 1, 2018, she is CMO of the Bachem Group and member of the Corporate Executive Committee. Anne-Kathrin Stoller studied chemistry in Hannover (Germany) and Cambridge (UK). After obtaining her doctorate under the supervision of Prof. Dr. Bernd Giese at the University of Basel (Switzerland), she started her career in the sales team of Exxonmobil Chemical.

 

Roland Schürmann (1964), Degree in Chemistry, COO, Swiss

since 2020

Roland Schürmann joined Bachem Americas, Inc. in Torrance, California in 2016. He was first Vice President Manufacturing and became Site Manager Torrance in May 2017. Roland Schürmann has been appointed COO of the Bachem Group and member of the Corporate Executive Committee effective July 1, 2020. After completing his education, he worked as a chemical laboratory technician at Ciba-Geigy AG and as a production chemist at F. Hoffmann-La Roche Ltd from 1984 to 1997. After holding various management positions at Siegfried AG in Zofingen, Switzerland, Roland Schürmann became Head of Chemical Production in 2004. Parallel to working, he was a senior lecturer for Chemical Technology from 1999 to 2015 at the vocational college in Aarau. Roland Schürmann has a university of applied sciences degree in chemistry from School of Engineering Burgdorf and is currently completing the Advanced Management Program at INSEAD Business School, Fontainebleau/Paris.